Basilea Pharmaceutica 주식 가격. 0QNA - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

프리미엄

가격

46.20

매수가

45.05

매도가

47.35

거래량

1,976

0.00 일간 변동폭 0.00

46.20 52주 범위 46.20

market_cap

554.492M

전일 종가

46.20

개장가

최근 거래 시간

45.85

(O)

마지막 거래 시간

재정 규모

VWAP

평균 볼륨(3m)

5,038

발행 주식

12,002,000

배당수익률

주가수익률

60.67

주당순이익(EPS)

0.87

매출

150.28M

순이익

10.45M

섹터

Pharmaceutical Preparations

산업

Pharmaceutical Preparations

웹사이트

www.basilea.com

본부

Basel, Che

설립됨

Basilea Pharmaceutica Ag is listed in the Pharmaceutical Preparations sector of the 런던증권거래소 with ticker 0QNA. The last closing price for Basilea Pharmaceutica was CHF46.20. Over the last year, Basilea Pharmaceutica shares have traded in a share price range of CHF 46.20 to CHF 46.20.

Basilea Pharmaceutica currently has 12,002,000 shares in issue. The market capitalisation of Basilea Pharmaceutica is CHF554.49 million. Basilea Pharmaceutica has a price to earnings ratio (PE ratio) of 60.67.

Basilea meldet für das Gesamtjahr 2024 ein starkes Ergebnis mit deutlichem Anstieg von Umsatz, Gewinn und operativem Cashflow

Basilea meldet für das Gesamtjahr 2024 ein starkes Ergebnis mit deutlichem Anstieg von Umsatz, Gewinn und operativem Cashflow Gesamtumsatz um 32 ...

Basilea erhält zusätzliche CARB-X-Förderung für die Entwicklung eines Medikamentenkandidaten einer neuen Antibiotika-Wirkstoffklasse

Basilea erhält zusätzliche CARB-X-Förderung für die Entwicklung eines Medikamentenkandidaten einer neuen Antibiotika-Wirkstoffklasse Zusätzliche...

기간	시가	고가	저가	평균 일일 거래량	VWAP
1	46.2	46.2	46.2	20440	46.2	DE
4	46.2	46.2	46.2	5747	46.2	DE
12	46.2	46.2	46.2	5038	46.2	DE
26	46.2	46.2	46.2	2732	46.2	DE
52	46.2	46.2	46.2	2235	46.2	DE
156	46.2	46.2	46.2	3848	46.2	DE
260	46.2	46.2	46.2	3933	46.2	DE

0QNA - Frequently Asked Questions (FAQ)

What is the current Basilea Pharmaceutica share price?

The current share price of Basilea Pharmaceutica is CHF 46.20

How many Basilea Pharmaceutica shares are in issue?

Basilea Pharmaceutica has 12,002,000 shares in issue

What is the market cap of Basilea Pharmaceutica?

The market capitalisation of Basilea Pharmaceutica is CHF 554.49M

What is the 1 year trading range for Basilea Pharmaceutica share price?

Basilea Pharmaceutica has traded in the range of CHF 46.20 to CHF 46.20 during the past year

What is the PE ratio of Basilea Pharmaceutica?

The price to earnings ratio of Basilea Pharmaceutica is 60.67

What is the cash to sales ratio of Basilea Pharmaceutica?

The cash to sales ratio of Basilea Pharmaceutica is 4.22

What is the reporting currency for Basilea Pharmaceutica?

Basilea Pharmaceutica reports financial results in CHF

What is the latest annual turnover for Basilea Pharmaceutica?

The latest annual turnover of Basilea Pharmaceutica is CHF 150.28M

What is the latest annual profit for Basilea Pharmaceutica?

The latest annual profit of Basilea Pharmaceutica is CHF 10.45M

What is the registered address of Basilea Pharmaceutica?

The registered address for Basilea Pharmaceutica is GRENZACHERSTRASSE 487, BASEL, 4058

What is the Basilea Pharmaceutica website address?

The website address for Basilea Pharmaceutica is www.basilea.com

Which industry sector does Basilea Pharmaceutica operate in?

Basilea Pharmaceutica operates in the PHARMACEUTICAL PREPARATIONS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
NARFNarf Industries Plc	0.40p (33.33%)	46.03M
AICAchilles Investment Company Limited	103.00p (25.61%)	86.71k
PYXPyx Resources Limited	2.97p (23.75%)	29.75k
VIDVidendum Plc	71.10p (21.54%)	514.93k
PRMProteome Sciences Plc	5.40p (19.73%)	271.02k
SCGLSealand Capital Galaxy Limited	1.25p (-28.57%)	34.5M
ZOOZoo Digital Group Plc	11.75p (-16.37%)	2.85M
AEGActive Energy Group Plc	0.275p (-15.38%)	688.46k
ARCArcontech Group Plc	79.00p (-14.59%)	419.19k
PREPensana Plc	19.50p (-12.56%)	1.16M
SYMESupply@me Capital Plc	0.004p (-1.23%)	314.44M
LLOYLloyds Banking Group Plc	68.54p (1.81%)	302.27M
GWMOGreat Western Mining Corporation Plc	0.011p (4.76%)	244.51M
ORCPOracle Power Plc	0.016p (-3.03%)	207.27M
MSMNMosman Oil And Gas Limited	0.037p (-3.90%)	181.22M

midastouch017 6 분 전

For a publicly traded company, when the up-front amount
isn’t specified it’s reasonable to infer that it’s small,
probably $5M or less.

RDHL

Louinjaxxx 8 분 전

That's because the company is not sell the 4's. The company has no control over those doing the selling.

AXXA

Nrdc92 9 분 전

And yet, I've been correct for 13 years posting about this garbage stock. Still, I'm happy that you've been "brave" enough to ignore the facts and power forward, as your losses mount daily. You are a true inspiration!

LWLG

Shawonsarker84 9 분 전

Bashers are way too overconfident seeing. 0003 today.

HMBL

robinandthe7hoods 10 분 전

Last summer,Gabriel Rene stated Verses would be seeing $300-400 million in revenue in 2025.
Could get interesting...

VRSSF

janice shell 10 분 전

One of the first articles about Trump's video, from Israel:

https://www.israelhayom.com/2025/02/26/trump-shares-gaza-ai-video-showing-him-netanyahu-sunbathing/

janice shell 11 분 전

One of the first articles, from Israel:

https://www.israelhayom.com/2025/02/26/trump-shares-gaza-ai-video-showing-him-netanyahu-sunbathing/

mick 11 분 전

hi there, good morning, been doing business

Viewmont 12 분 전

$PRPH https://www.prophaselabs.com/

PRPH

janice shell 13 분 전

I wonder what the reaction will be tomorrow. And WHAT is it with those two male belly dancers?

clokisticking 15 분 전

Hey FAT FISH … Is that you doing that last trade red paint job ???

VDRM

lodas 15 분 전

@ stockjock.......all of the filings that I read stated that WMIH, as successor to WMI owned the Estate, and Title to all assets, along with JPM, FDIC, and the WMIL-T......so, it is not inconceivable that DBNT, who held the 99 Trusts in the corporate name of WMI, would turn them back to the owner WM

JPM

clokisticking 17 분 전

What a BS red paint job last trade … 1500 shares at .0011 for a grand total of $1.65 cents. Such BS games … I hope no one will fall for the appearance of the sky is falling. Rediculous 🤷🏼

VDRM

Nukemtiltheyglow 17 분 전

Job opportunities, yes, ex Military, big yes!! Look up a company named GD Barri. They're a recruiter for the Nuclear Power industry. Depending on what you did in the military could be a real plus. Project Coordinator, Project Management, Scheduling, any trade skills?

AMRN

NYBob 18 분 전

MAGA NEWS - Trump Responds To Movement In Canada To Become 51st State
Forbes Breaking News
4.51M subscribers

[yt]uYYTVowzs-I[/yt]

https://www.youtube.com/watch?v=uYYTVowzs-I

Just Now: No More Property Taxes Announced In Multiple States (Ful

ARIS HGLD PATAGONIA

JoeForkeyBolo 19 분 전

man we are starving for some GOOD news!!!!
https://investorshub.advfn.com/uimage/uploads/2025/2/26/obtjq9liwox-1.jpg

MONI

NYBob 21 분 전

Trump Responds To Movement In Canada To Become 51st State
Forbes Breaking News
4.51M subscribers

[yt]uYYTVowzs-I[/yt]

https://www.youtube.com/watch?v=uYYTVowzs-I

Just Now: No More Property Taxes Announced In Multiple States (Full Details )

ARIS HGLD PATAGONIA

Sammy boy 22 분 전

2 AH’s with multiple ID’s still talking to each other, LMFAO !

FNMA

NYBob 23 분 전

STAR NEWS - Trump Responds To Movement In Canada To Become 51st State
Forbes Breaking News
4.51M subscribers

[yt]uYYTVowzs-I[/yt]

https://www.youtube.com/watch?v=uYYTVowzs-I

Just Now: No More Property Taxes Announced In Multiple States (Ful

ARIS HGLD PATAGONIA

dalesio_98 23 분 전

New money98,

You respond to my question with a question. SMH LOL

Good luck to All!

SMH

IGPK

yes- I did see that person.

4retire 27 분 전

Tomorrow is a big day (hopefully) for IONQ and NVDA. The current business climate needs a big winner. Hopefully these two companies can hit it out of the park tomorrow afternoon. Waiting in anticipation like a kid on Christmas Eve. GLTA

IONQ NVDA

ron_66271 30 분 전

Your Poor Math Skills are Your Problem.

Ron

COOP

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Basilea Pharmaceutica Ag (0QNA)

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

Basilea Pharmaceutica Ag 정보

0QNA 최신 뉴스

Basilea meldet für das Gesamtjahr 2024 ein starkes Ergebnis mit deutlichem Anstieg von Umsatz, Gewinn und operativem Cashflow

Basilea reports strong 2024 full-year results with significant increase in revenue, profit and operating cash flow

Starker Verkaufsstart von Cresemba in Japan löst erste Umsatzmeilensteinzahlung von AKP an Basilea aus

Strong launch for Cresemba in Japan triggers first sales milestone payment from AKP to Basilea

Starkes Verkaufswachstum von Cresemba und Zevtera löst weitere Meilensteinzahlungen an Basilea aus

Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea

Basilea informiert über Stand seines Portfolios und gibt Ausblick

Basilea provides portfolio update and outlook

Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics

Basilea erhält zusätzliche CARB-X-Förderung für die Entwicklung eines Medikamentenkandidaten einer neuen Antibiotika-Wirkstoffklasse

Basilea meldet für das Gesamtjahr 2024 ein starkes Ergebnis mit deutlichem Anstieg von Umsatz, Gewinn und operativem Cashflow

Basilea reports strong 2024 full-year results with significant increase in revenue, profit and operating cash flow

Strong launch for Cresemba in Japan triggers first sales milestone payment from AKP to Basilea

Starker Verkaufsstart von Cresemba in Japan löst erste Umsatzmeilensteinzahlung von AKP an Basilea aus

Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea

Starkes Verkaufswachstum von Cresemba und Zevtera löst weitere Meilensteinzahlungen an Basilea aus

Basilea provides portfolio update and outlook

Basilea informiert über Stand seines Portfolios und gibt Ausblick

0QNA - Frequently Asked Questions (FAQ)

이동자

토론

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Basilea Pharmaceutica Ag (0QNA) 시세

Basilea Pharmaceutica Ag (0QNA)

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

Basilea Pharmaceutica Ag 정보

0QNA 최신 뉴스

Basilea meldet für das Gesamtjahr 2024 ein starkes Ergebnis mit deutlichem Anstieg von Umsatz, Gewinn und operativem Cashflow

Basilea reports strong 2024 full-year results with significant increase in revenue, profit and operating cash flow

Starker Verkaufsstart von Cresemba in Japan löst erste Umsatzmeilensteinzahlung von AKP an Basilea aus

Strong launch for Cresemba in Japan triggers first sales milestone payment from AKP to Basilea

Starkes Verkaufswachstum von Cresemba und Zevtera löst weitere Meilensteinzahlungen an Basilea aus

Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea

Basilea informiert über Stand seines Portfolios und gibt Ausblick

Basilea provides portfolio update and outlook

Basilea is awarded additional CARB-X funding to develop new drug candidate from a novel class of antibiotics

Basilea erhält zusätzliche CARB-X-Förderung für die Entwicklung eines Medikamentenkandidaten einer neuen Antibiotika-Wirkstoffklasse

Basilea meldet für das Gesamtjahr 2024 ein starkes Ergebnis mit deutlichem Anstieg von Umsatz, Gewinn und operativem Cashflow

Basilea reports strong 2024 full-year results with significant increase in revenue, profit and operating cash flow

Strong launch for Cresemba in Japan triggers first sales milestone payment from AKP to Basilea

Starker Verkaufsstart von Cresemba in Japan löst erste Umsatzmeilensteinzahlung von AKP an Basilea aus

Strong sales growth for Cresemba and Zevtera trigger further milestone payments to Basilea

Starkes Verkaufswachstum von Cresemba und Zevtera löst weitere Meilensteinzahlungen an Basilea aus

Basilea provides portfolio update and outlook

Basilea informiert über Stand seines Portfolios und gibt Ausblick

0QNA - Frequently Asked Questions (FAQ)

이동자

토론

최근 히스토리

회사 소개

사업

Popular

앱 받기

광고 제거